TipRanks
Go Ultimate55% OFF

Petco Health and Wellness Company (WOOF) AI Stock Analysis

MX:WOOF

Petco Health and Wellness Company

(BMV:WOOF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Cash Generation and Debt ReductionImproving free cash flow gives Petco greater capacity to fund operations, invest in stores and services, and reduce debt internally. Recent debt paydown also lowers financial pressure over time, although maintaining this cash conversion through different retail cycles remains important.
Negative Factors
Thin Profitability and Limited GrowthVery thin profitability leaves limited protection against cost inflation, promotional activity, or demand softness. Broadly flat revenue also suggests the recent improvement is stabilization rather than strong expansion, making sustained margin improvement necessary for earnings to become more resilient.

Petco Health and Wellness Company (WOOF) vs. SPDR S&P 500 ETF (SPY)

-50%-40%-30%-20%-10%0%10%20%MX:WOOF-28.36%SPY+12.58%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 784.79M
Dividend Yield
―
Average Volume (3M)
2,241
Price to Earnings (P/E)
24.8
Beta (1Y)
0.19
Revenue Growth
-10.95%
EPS Growth
―
Country
Mexico
Employees
29,000
Sector
Consumer Cyclical
Sector Strength
61
Industry
Specialty Retail

Petco Health and Wellness Company Business Overview & Revenue Model

Company Description

Petco Health and Wellness Company, Inc. operates as an enterprise focused on enhancing the well-being of companion animals, their human guardians, and its own associates. The company offers a broad spectrum of services, including veterinary care (pro...

Petco Health and Wellness Company Earnings Call Summary

Earnings Call Date:Sep 01, 2026(Q2-2026)|% Change Since:4.01%|Next Earnings Date:Dec 01, 2026
Earnings Call SentimentPositive

The call was predominantly positive. Petco delivered a second consecutive quarter of positive comparable sales, exceeded its normalized EBITDA outlook, generated strong cash flow, reduced debt and reaffirmed full-year guidance. Management also cited improving customer trends, veterinary growth, cat-category momentum, e-commerce recovery and encouraging store-format results. The principal negatives were the temporary sales impact from the Petco Perks relaunch, continued softness in the dog business, ongoing manageable supply-chain headwinds, slower-than-expected owned-brand progress and continued weakness in supplies.

Positive Updates

Second Consecutive Positive Comparable Sales Quarter
Second-quarter net sales were $1.5 billion, up slightly from last year, with a 0.6% comparable-sales increase. This marked Petco's second consecutive quarter of positive comps.

Negative Updates

Membership Relaunch Temporarily Reduced Q2 Sales
The national Petco Perks rollout led to point redemption volumes that far exceeded initial projections. While this demonstrated strong customer engagement, it negatively affected second-quarter net sales, particularly in services. Management estimated the impact at mid-single-digit millions, based on sales tracking above the approximately 0.3% outlook before the rollout versus sales reported as approximately flat.

Company Guidance

Petco affirmed its full-year outlook, continuing to expect net sales of flat to up 1.5% compared to last year and adjusted EBITDA to be between $415 million and $430 million. For the third quarter, it expects sales growth of 0.4% to 1% year over year and adjusted EBITDA to be between $100 million and $103 million; it now expects net interest expense to be about $122 million, depreciation and amortization about $200 million, capital expenditures of about $140 million, and net store closures between 15 and 20. Petco expects to complete its Hill's Science Diet Single Protein Dog Food Rolls rollout by year end, expects a positive impact from its new membership program to emerge in 2027, and remains on track to begin to open additional vet hospitals in 2027.

Petco Health and Wellness Company Risk Analysis

Petco Health and Wellness Company disclosed 68 risk factors in its most recent earnings report. Petco Health and Wellness Company reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Petco Health and Wellness Company Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

MX:WOOF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AMZNAMZN74Outperform$2.59T19.5926.71%―15.35%73.92%
CHWYCHWY66Neutral$8.56B33.7462.13%―5.86%81.66%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
TSCOTSCO60Neutral$17.68B18.9837.64%2.69%3.53%-10.44%
PETSPETS48Neutral$25.80M-0.87-91.67%―-19.67%34.91%
BARKBARK43Neutral$72.27M-2.30-39.54%―-21.25%-5.40%

* Consumer Cyclical Sector Average

Performance Comparison

-50%-25%0%25%50%MX:WOOFAMZNPETSTSCOCHWYBARKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:WOOF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:WOOFPetco Health And Wellness Company Inc48.00-19.00-28.36%
AMZNAmazon.Com, Inc.245.63-3.69-1.48%
PETSPetmed Express1.20-1.27-51.42%
TSCOTractor Supply Company35.31-16.49-31.84%
CHWYChewy Inc22.27-11.52-34.09%
BARKBARK Inc Class A8.29-7.75-48.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.